TejaswiniKulkarniMD

Pulmonology • Birmingham, AL

Critical Care Medicine, Interstitial Lung Diseases, Occupational & Environmental Lung Disease

Physician

Join to view full profile

Dr. Kulkarni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kulkarni's full profile

Already have an account?

Office
1717 6th Ave S
Birmingham, AL 35233
Phone+1 800-822-8816

Education & Training

University of Alabama Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2016
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2010 - 2013
Bangalore Medical CollegeClass of 2008

Certifications & Licensure

AL State Medical License 2013 - 2025
MI State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis Start of enrollment: 2023 May 15
Recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

"Breathing Through the Years": A Call for Combating Breathlessness, Frailty, and Sarcopenia in Older Adults.
Tejaswini Kulkarni, Merry Lynn McDonald
Chest. 2024-12-01
Persistence of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Pulmonary Fibrosis Foundation Patient Registry Study.
Tejaswini Kulkarni, Kevin Flaherty, Sachin Gupta, Yi-Hsuan Tu, Amy Hajari Case
Annals of the American Thoracic Society. 2024-10-15
The Impact of Autoantibodies on Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analyses of the Phase III ASCEND Trial.
Tejaswini Kulkarni, Chad A Newton, Sachin Gupta, Katerina Samara, Elana J Bernstein
Pulmonary Therapy. 2024-09-01

Authored Content

An Update in Progressive Pulmonary FibrosisOctober 2022

Press Mentions

Pulmonary and Primary Care Experts Share Clinician Toolkit on Rare Disease Day to Raise Awareness for Interstitial Lung DiseaseFebruary 28th, 2023
Pulmonary and Primary Care Experts Share Research on Delays to Diagnosis in Complex Lung DiseasesSeptember 19th, 2022
Autoantibody Reduction Regimen Improves Lungs, Survival: StudyDecember 14th, 2021
Join now to see all